Bret Berner - Concepedia

Author

Bret Berner

Novartis (Switzerland)

Also Known As

B Berner, B D Berner, B. Berner, Bret Berner, Bret. Berner

Publications

2.2K

Citations

H-Index

100

Concepts

All Affiliations

Novartis (Switzerland)Depomed (United States)Menlo School University of California, San Francisco Cygnus (United States)

About

Bret Berner is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	694
2	Engineering	12	15	438
3	Natural Sciences	2	2	47
4	Health Sciences	1	1	48
5	Public Health	1	1	15

Bret Berner

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Ethanol: Water Mutually Enhanced Transdermal Therapeutic System II: Skin Permeation of Ethanol and Nitroglycerin Bret Berner, Gerard C. Mazzenga, John H. Otte, Journal of Pharmaceutical Sciences MedicineTopical DrugSkin SubstituteSkin PharmacologyWound Healing	1989	187
Efficacy, Tolerability, and Safety of a Novel Once-Daily Extended-Release Metformin in Patients With Type 2 Diabetes Sherwyn Schwartz, Vivian Fonseca, Bret Berner, Diabetes Care	2006	130
Transbuccal Delivery of Acyclovir: I. In Vitro Determination of Routes of Buccal Transport Amir H. Shojaei, Bret Berner, Xiaoling Li Pharmaceutical Research	1998	101
Pharmacokinetics of Metformin Gastric‐Retentive Tablets in Healthy Volunteers G. Gusler, Jane Gorsline, G Lévy, The Journal of Clinical Pharmacology	2001	91
Buccal Permeation of Buspirone: Mechanistic Studies on Transport Pathways Raj Birudaraj, Bret Berner, Steve I Shen, Journal of Pharmaceutical Sciences Membrane TransportBuccal PermeationTransport PhenomenaScalar TransportMass Transfer	2004	89
Electrochemical and iontophoretic studies of human skin John D. DeNuzzio, Bret Berner Journal of Controlled Release EngineeringAnalytical ChemistryElectrophysiologyHuman SkinDermatology	1990	88
Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: A randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects Toufigh Gordi, Eddie Hou, Sreeneeranj Kasichayanula, Clinical Therapeutics Steady StateHealthy SubjectsPharmacological StudyMedicineThree-way Crossover	2008	60
The electron spin resonance line width method for measuring diffusion. A critique Bret Berner, Daniel Kivelson The Journal of Physical Chemistry EngineeringMagnetic ResonanceAltmetric Attention ScoreBibliometricsAltmetrics	1979	57
Ethanol and Water Sorption into Stratum Corneum and Model Systems Bret Berner, Rong‐Hwei Juang, Gerard C. Mazzenga Journal of Pharmaceutical Sciences Chemical EngineeringBiomanufacturingStratum CorneumDermatologyMedicine	1989	56
OP0307 Efficacy and safety of risankizumab, a selective il-23p19 inhibitor, in patients with active psoriatic arthritis over 24 weeks: results from a phase 2 trial Philip J. Mease, H. Kellner, Akimichi Morita, Annals of the Rheumatic Diseases	2018	53

Page 1